scholarly article | Q13442814 |
P50 | author | David Nutt | Q3277223 |
Ben Fletcher-Watson | Q61415191 | ||
Lula Rosso | Q114411116 | ||
Nicola J. Kalk | Q37828686 | ||
David J. Brooks | Q38329590 | ||
Anne Lingford-Hughes | Q41330622 | ||
Federico Turkheimer | Q41330642 | ||
P2093 | author name string | Sue J Wilson | |
Nicoletta Clementi | |||
James F M Myers | |||
P2860 | cites work | Benzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil. | Q51650434 |
Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle | Q59845561 | ||
Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography | Q59858902 | ||
Physical characteristics of the ECAT EXACT3D positron tomograph | Q73014085 | ||
Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human [...] | Q24316082 | ||
Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging data | Q30648196 | ||
Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans | Q33857924 | ||
A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method | Q34009095 | ||
A new benzodiazepine pharmacology. | Q34106026 | ||
Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications | Q34367180 | ||
The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agents | Q35854608 | ||
GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits | Q36790682 | ||
Exact and approximate rebinning algorithms for 3-D PET data. | Q36853656 | ||
Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different | Q39923376 | ||
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. | Q40417870 | ||
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomography | Q41979083 | ||
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited | Q42414770 | ||
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy | Q43569633 | ||
Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography | Q44079767 | ||
Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomography | Q44257887 | ||
Quantitative analyses of [¹¹C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brain | Q45834704 | ||
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic study | Q46466765 | ||
Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist | Q46777275 | ||
Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies | Q46956296 | ||
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist | Q46987358 | ||
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study | Q47675005 | ||
The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization procedures | Q48127599 | ||
Saturation analysis in PET--analysis of errors due to imperfect reference regions | Q48164782 | ||
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist. | Q48306835 | ||
Spectral analysis of dynamic PET studies | Q48366094 | ||
Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic space | Q48557699 | ||
Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia | Q48823105 | ||
A subclass of GABAA/benzodiazepine receptor exclusively localized in the limbic system | Q48827946 | ||
Simplified reference tissue model for PET receptor studies. | Q48832665 | ||
A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions. | Q51036179 | ||
Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo. | Q51580734 | ||
P433 | issue | 4 | |
P304 | page(s) | 731-744 | |
P577 | publication date | 2012-01-04 | |
P1433 | published in | Journal of Cerebral Blood Flow & Metabolism | Q14663525 |
P1476 | title | Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images | |
P478 | volume | 32 |